5-HT1D receptor
Assets acting on this target.
- Class
- Ergot alkaloid 5-HT1D receptor agonist (also binds other 5-HT, adrenergic and dopamine receptors)
By indication
5-HT1D receptor drugs compared
5 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Dihydroergotamine (Atzumi)Atzumi | Shin Nippon Biomedical Laboratories | small molecule | Approved | Approved in Migraine |
| Dihydroergotamine mesylate (Brekiya)Brekiya | Amneal Pharmaceuticals | small molecule | Approved | Approved in Migraine |
| Dihydroergotamine mesylate (D.H.E. 45)D.H.E. 45 | Bausch Health | small molecule | Approved | Approved in Migraine |
| Dihydroergotamine mesylate (Migranal)Migranal | Advanz Pharma, Bausch Health | small molecule | Approved | Approved in Migraine |
| Dihydroergotamine mesylate/Dipyrone/Caffeine (Cefaliv)Cefaliv | Aché Laboratórios Farmacêuticos S.A. | Not recorded | Stage not recorded | Not recorded |